Dyslipidemia and Associated Factors in Tenofovir Disoproxil Fumarate-Based Regimen Among Human Immunodeficiency Virus-Infected Ethiopian Patients: A Hospital-Based Observational Prospective Cohort Study.
Taklo Simeneh YaziePublished in: Drug, healthcare and patient safety (2020)
In this study, the proportion of patients with dyslipidemia was higher at six month follow-up but there was no significant difference when compared to baseline. The mean LDL-c was significantly higher at six months compared to its baseline mean. The associated factors with dyslipidemia were age, BMI, having cancer and low level of education. Lipid profile monitoring is recommended in patients with a younger age and higher BMI.
Keyphrases
- human immunodeficiency virus
- antiretroviral therapy
- hepatitis c virus
- end stage renal disease
- body mass index
- ejection fraction
- newly diagnosed
- healthcare
- hiv infected
- papillary thyroid
- weight gain
- peritoneal dialysis
- hiv aids
- patient reported outcomes
- squamous cell carcinoma
- physical activity
- hiv positive
- quality improvement
- cross sectional
- patient reported
- lymph node metastasis